JP2021519311A5 - - Google Patents
Info
- Publication number
- JP2021519311A5 JP2021519311A5 JP2020551971A JP2020551971A JP2021519311A5 JP 2021519311 A5 JP2021519311 A5 JP 2021519311A5 JP 2020551971 A JP2020551971 A JP 2020551971A JP 2020551971 A JP2020551971 A JP 2020551971A JP 2021519311 A5 JP2021519311 A5 JP 2021519311A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- composition according
- acid sequence
- amino acid
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862650235P | 2018-03-29 | 2018-03-29 | |
| US62/650,235 | 2018-03-29 | ||
| PCT/US2019/024854 WO2019191598A1 (en) | 2018-03-29 | 2019-03-29 | Antimicrobial, bacteriophage-derived polypeptides and their use against gram-negative bacteria |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021519311A JP2021519311A (ja) | 2021-08-10 |
| JP2021519311A5 true JP2021519311A5 (https=) | 2022-04-01 |
Family
ID=68058481
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020551971A Pending JP2021519311A (ja) | 2018-03-29 | 2019-03-29 | 抗微生物性バクテリオファージ由来ポリペプチド及びグラム陰性細菌に対するそれらの使用 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20210330738A1 (https=) |
| EP (1) | EP3773669A4 (https=) |
| JP (1) | JP2021519311A (https=) |
| KR (1) | KR20210005027A (https=) |
| CN (1) | CN112368010A (https=) |
| AU (1) | AU2019245333A1 (https=) |
| BR (1) | BR112020019010A2 (https=) |
| CA (1) | CA3096236A1 (https=) |
| IL (1) | IL277399A (https=) |
| MX (1) | MX2020010071A (https=) |
| WO (1) | WO2019191598A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112368376A (zh) | 2018-03-29 | 2021-02-12 | 康特拉费克特公司 | 溶素-抗微生物肽(amp)多肽构建体、溶素、其分离的编码多核苷酸及其用途 |
| WO2021007107A1 (en) * | 2019-07-05 | 2021-01-14 | Contrafect Corporation | Antimicrobial, bacteriophage-derived polypeptides and their use against gram-negative and acid-fast bacteria |
| US20220411473A1 (en) * | 2019-11-14 | 2022-12-29 | Contrafect Corporation | Lysin-antimicrobial peptide (amp) polypeptide constructs, lysins, isolated polynucleotides encoding same and uses thereof |
| WO2021211303A1 (en) * | 2020-04-14 | 2021-10-21 | Contrafect Corporation | Antiviral, bacteriophage-derived polypeptides and their use against viruses |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2447823A1 (en) * | 2001-05-23 | 2002-11-28 | The University Of British Columbia | Diagnosis of vascular disease susceptibility using bacteriophage phi-cpn1 host chlamydia |
| WO2004104174A2 (en) * | 2003-05-16 | 2004-12-02 | North Carolina State University | Polyubiquitin rubi3 promoter and 5' regulatory sequences |
| CA2989778C (en) * | 2007-01-19 | 2020-06-30 | Kai Pharmaceuticals, Inc. | Method of modifying peptide compositions |
| WO2010141135A2 (en) * | 2009-03-05 | 2010-12-09 | Trustees Of Boston University | Bacteriophages expressing antimicrobial peptides and uses thereof |
| SG11201405721VA (en) * | 2012-03-19 | 2014-10-30 | Madeleine Pharmaceuticals Ρτy Ltd | Method of producing a recombinant peptide |
| AU2016324307B2 (en) * | 2015-09-17 | 2021-10-21 | Contrafect Corporation | Use of lysin to restore/augment antibacterial activity in the presence of pulmonary surfactant of antibiotics inhibited thereby |
| CN112368376A (zh) * | 2018-03-29 | 2021-02-12 | 康特拉费克特公司 | 溶素-抗微生物肽(amp)多肽构建体、溶素、其分离的编码多核苷酸及其用途 |
| WO2020046747A1 (en) * | 2018-08-23 | 2020-03-05 | Contrafect Corporation | Lysin-antimicrobial peptide (amp) polypeptide constructs, lysins, isolated polynucleotides encoding same and uses thereof |
| WO2021007107A1 (en) * | 2019-07-05 | 2021-01-14 | Contrafect Corporation | Antimicrobial, bacteriophage-derived polypeptides and their use against gram-negative and acid-fast bacteria |
| US20220411473A1 (en) * | 2019-11-14 | 2022-12-29 | Contrafect Corporation | Lysin-antimicrobial peptide (amp) polypeptide constructs, lysins, isolated polynucleotides encoding same and uses thereof |
| US20210324359A1 (en) * | 2020-04-17 | 2021-10-21 | Contrafect Corporation | Use of gram-negative lysin-antimicrobial peptide (amp) polypeptide constructs in treating endocarditis |
-
2019
- 2019-03-29 US US17/041,638 patent/US20210330738A1/en not_active Abandoned
- 2019-03-29 MX MX2020010071A patent/MX2020010071A/es unknown
- 2019-03-29 KR KR1020207030981A patent/KR20210005027A/ko not_active Withdrawn
- 2019-03-29 WO PCT/US2019/024854 patent/WO2019191598A1/en not_active Ceased
- 2019-03-29 BR BR112020019010-1A patent/BR112020019010A2/pt unknown
- 2019-03-29 EP EP19774811.4A patent/EP3773669A4/en active Pending
- 2019-03-29 JP JP2020551971A patent/JP2021519311A/ja active Pending
- 2019-03-29 AU AU2019245333A patent/AU2019245333A1/en not_active Abandoned
- 2019-03-29 CN CN201980036013.5A patent/CN112368010A/zh active Pending
- 2019-03-29 CA CA3096236A patent/CA3096236A1/en active Pending
-
2020
- 2020-09-16 IL IL277399A patent/IL277399A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021519083A5 (https=) | ||
| IL277119B1 (en) | Antimicrobial lysine-peptide polypeptide templates, lysines, isolated polynucleotides encoding them and uses thereof | |
| JP2021519311A5 (https=) | ||
| US20250064902A1 (en) | Use of lysin to restore/augment antibacterial activity in the presence of pulmonary surfactant of antibiotics inhibited thereby | |
| JP2024010053A5 (https=) | ||
| US11180744B2 (en) | Acinetobacter lysins | |
| AU758698B2 (en) | Anti-endotoxic, antimicrobial cationic peptides and methods of use therefor | |
| JP2023517245A5 (https=) | ||
| JP2024010053A (ja) | シュードモナス・エルギノーサに対する殺菌活性を有する溶解素及びその誘導体の特定 | |
| CN112218659A (zh) | 用于治疗葡萄球菌感染的治疗性噬菌体组合物 | |
| RU2020128276A (ru) | МОДИФИЦИРОВАННЫЕ ЛИЗИНЫ PlySs2 И ВАРИАНТЫ ИХ ПРИМЕНЕНИЯ | |
| JP2022539383A5 (https=) | ||
| JP2021513865A5 (https=) | ||
| JP2021508501A (ja) | Ｐｓｅｕｄｏｍｏｎａｓ感染症を処置するためのバクテリオファージ組成物 | |
| JP2022526978A5 (https=) | ||
| JP2023502940A5 (https=) | ||
| RU2020131450A (ru) | Происходящие из бактериофагов противомикробные полипептиды и их применение против грамотрицательных бактерий | |
| RU2021137156A (ru) | Происходящие из бактериофагов противомикробные полипептиды и их применение против грамотрицательных и кислотоустойчивых бактерий | |
| KR20140120706A (ko) | 황색포도알균에 특이적 항균 활성을 가지는 리신 융합 단백질 및 이의 용도 | |
| Kuhn et al. | Antimicrobial peptides in lung health and pulmonary diseases | |
| US20220387563A1 (en) | Novel polypeptides and antibiotics against Gram-negative bacterium comprising the same | |
| RU2022126282A (ru) | Новый рекомбинантный лизин и его применение в лечении грамотрицательных бактериальных инфекций | |
| HK40086790A (en) | Use of lysin to restore/augment antibacterial activity in the presence of pulmonary surfactant of antibiotics inhibited thereby | |
| WO2025172452A1 (en) | Combination for treating bacterial infection due to pseudomonas aeruginosa antibiotic-resistant strain | |
| CN106420734B (zh) | 一种杀灭金黄色葡萄球菌persister休眠细胞的清除剂 |